---
figid: PMC6635658__fphar-10-00690-g007
figtitle: Schematic model depicting the possible mechanisms of nobiletin-mediated
  inhibition of renal cancer cell proliferation
organisms:
- NA
pmcid: PMC6635658
filename: fphar-10-00690-g007.jpg
figlink: /pmc/articles/PMC6635658/figure/f7/
number: F7
caption: Schematic model depicting the possible mechanisms of nobiletin-mediated inhibition
  of renal cancer cell proliferation. AKT regulates the translocation of STAT3 and
  YY1AP1 to the nucleus. Nobiletin inhibits the SRC/AKT pathway and reduces STAT3
  and YY1AP1 activation, thus contributing to the inhibition of cell proliferation.
papertitle: Nobiletin Inhibits Cell Viability via the SRC/AKT/STAT3/YY1AP1 Pathway
  in Human Renal Carcinoma Cells.
reftext: Di Wei, et al. Front Pharmacol. 2019;10:690.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9646689
figid_alias: PMC6635658__F7
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6635658__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6635658__fphar-10-00690-g007.html
  '@type': Dataset
  description: Schematic model depicting the possible mechanisms of nobiletin-mediated
    inhibition of renal cancer cell proliferation. AKT regulates the translocation
    of STAT3 and YY1AP1 to the nucleus. Nobiletin inhibits the SRC/AKT pathway and
    reduces STAT3 and YY1AP1 activation, thus contributing to the inhibition of cell
    proliferation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SRC
  - FGR
  - FYN
  - YES1
  - AKT1
  - AKT2
  - AKT3
  - STAT3
  - YY1AP1
---
